Clinical Trial

Development of a Biological Database in the Field of Operative Intensive Care

Study acronym: Biobank OIM
Recruiting
View on ClinicalTrials.gov →
Summary
The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-01-06; most recent amendment 2019-09-17.
Status change: Not Yet Recruiting → Recruiting 2017-04-07
Trial Details
NCT Number NCT03014427
Lead Sponsor RWTH Aachen University
Conditions Intensive Care in General
Enrollment 99,999,999 participants
Start Date 2017-03-01
Primary Completion 2050-02 (estimated)
Study Completion 2050-02 (estimated)
Updated on ClinicalTrials.gov 2019-09-18